# Pregnant maternal brain dorsal anterior cingulate cortex choline/creatine ratios on 1H-MR spectroscopy in opioid exposure

**Authors:** Jonathan A. Class, Ramana V. Vishnubhotla, Yi Zhao, Nathan Ooms, David M. Haas, Senthilkumar Sadhasivam, Rupa Radhakrishnan

PMC · DOI: 10.3389/fnins.2025.1569558 · Frontiers in Neuroscience · 2025-04-16

## TL;DR

This study explores how opioid use during pregnancy affects brain metabolism in the dorsal anterior cingulate cortex using magnetic resonance spectroscopy.

## Contribution

The study identifies elevated choline-to-creatine ratios in pregnant women on opioid medications, offering new insights into the neurobiological effects of opioid exposure during pregnancy.

## Key findings

- Opioid exposure was positively associated with choline-to-creatine (Cho/Cr) ratios in the dACC after adjusting for gestational age and scanner site.
- Pregnant women on MOUD with polysubstance exposure had significantly higher Cho/Cr ratios compared to those without additional substance exposure and control subjects.
- Altered Cho/Cr ratios in the dACC may reflect neurometabolic changes linked to opioid use during pregnancy.

## Abstract

There is growing interest in understanding the effects of opioid use on the brain, yet the effects of opioid use on the pregnant maternal brain are still relatively unknown. Pregnant women with opioid exposure during pregnancy are at high risk for adverse neurological and neuropsychiatric outcomes. Much of what is currently known about the impact of opioids on the maternal brain is mainly derived from studies in animal models; however, species-specific opioid pathways and other socio-environmental factors complicate the interpretation of results. A few studies in non-pregnant adults have shown the utility of magnetic resonance spectroscopy (MRS) in risk prediction in substance exposure. We know that pregnancy alters the pharmacodynamics and pharmacokinetics of opioid metabolism, and the impact of opioids on synapses may differ during pregnancy compared to the non-pregnant state. We, therefore, aimed to understand the neurometabolic alterations in pregnant women on medications for opioid use disorder (MOUD). In our multicenter study, we utilized 1H MRS to analyze metabolic alterations in the dorsal anterior cingulate cortex (dACC) in pregnant women on MOUD (12 subjects) vs. pregnant control women (21 subjects) without substance exposure. Using multivariable linear regression, we identified a positive association between opioid exposure and choline-to-creatine (Cho/Cr) ratios after correcting for gestational age and scanner site. We also identified a significant elevation in the Cho/Cr ratio in pregnant women on MOUD and concomitant polysubstance exposure when compared to pregnant women on MOUD without exposure to other substances and control pregnant women. These altered metabolite concentrations that we identified in the dACC may provide a mechanistic understanding of the neurobiology of MOUD and insights for better management and outcomes.

## Linked entities

- **Chemicals:** opioid (PubChem CID 126961754)

## Full-text entities

- **Diseases:** neuropsychiatric (MESH:C000631768), MOUD (MESH:D009293)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12040935/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12040935/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12040935/full.md

---
Source: https://tomesphere.com/paper/PMC12040935